Medications for Diabetes Flashcards
Insulin MOA
initiates glucose uptake into cells that are insulin-dependent
Amylin Analogs MOA
Slows gastric emptying, suppresses glucagon secretion, promotes satiety
GLP-1 receptor agonist MOA
Promotes glucose-dependent insulin secretion, inhibits the post-prandial release of glucagon, slows gastric emptying, suppresses appetite
Acts like endogenous GLP-1, but longer lasting
Biguanides MOA
Increase sensitivity of insulin receptors
Decrease liver gluconeogenesis
Sulfonylureas MOA
Stimulate insulin release (secretagogue)
Meglitinides MOA
Stimulate insulin release (secretagogue)
Alpha-glucosidase inhibitors MOA
Inhibit enzymes at GI brush border –> inhibits absorption of ingested carbohydrates
Thiazolidinediones MOA
insulin sensitizers
Dipeptidyl Peptidase-4 (DPP-4) Inhibitors MOA
slow incretin inactivation by DPP-4 enzyme
Stimulate glucose-dependent insulin release and inhibit postprandial glucagon release
Sodium-glucose linked transporter-2 (SGLT-2) Inhibitors MOA
Reduce the reabsorption of glucose by the kidneys
Levels of hypoglycemia
Level 1: <70
Level 2: <54
Level 3: altered mental and/or physical status
Levels of hypoglycemia
Level 1: <70
Level 2: <54
Level 3: altered mental and/or physical status
U-500 syringes are _____ while U-100 are _____
U-500 syringes are GREEN
U-100 are ORANGE
Rapid Acting Insulin
Aspart
Lispro
Glulisine
Short Acting Insulin
Regular/Human